INTRODUCTION
Cell stimulation by insulin leads to the activation of the insulin receptor tyrosine kinase and the subsequent phosphorylation of IRS 1 [1, 2] . This protein contains several tyrosine phosphorylation motifs which are substrates for the insulin receptor, and bind several proteins containing SH2 (Src homology 2) domains [2, 3] . In addition, IRS 1 has many potential serine/threonine phosphorylation sites and has been shown to be phosphorylated on serine and threonine residues in unstimulated cells [3, 4] . Insulin induces not only the tyrosine phosphorylation of IRS 1 but also enhances its serine/threonine phosphorylation [3, 4] . Although IRS 1 contains consensus sites for cyclic AMP (cAMP)-dependent protein kinase, protein kinase C, mitogen-activated protein kinase and casein kinase II [4] , the kinase(s) responsible for IRS 1 phosphorylation after exposure of cells to insulin is (are) not known. One of them could be casein kinase II, which phosphorylates IRS 1 in vitro. Furthermore, some of the phosphopeptides phosphorylated in an insulin-sensitive manner in vivo correspond to peptides phosphorylated by casein kinase II [5] . The role of IRS 1 serine/threonine phosphorylation in insulin action remains ill-defined. However, a series of observations suggest that it could be a part of a feed-back loop involved in attenuation of the insulin signal. Indeed, in 3T3-L1 adipocytes, okadaic acid stimulates a serine/threonine kinase activity towards IRS 1, and the resulting hyperphosphorylation of IRS 1 has been linked to a reduction in its tyrosine phosphorylation by the insulin receptor and a blockade in insulin action [6] . It is possible that serine/threonine kinases become associated with IRS 1 after insulin stimulation and thus modulate the insulin signalling pathway. The proteins that bind to tyrosinephosphorylated IRS 1 include only one identified kinase: phosphatidylinositol . This enzyme is composed of two subunits: a p85 regulatory subunit which contains SH2 domains [7] [8] [9] , and a p1O subunit which is the catalytic subunit [10] . P13-kinase is activated after binding of the p85 of the phosphatidylinositol 3-kinase (PI3-kinase). Importantly, in an in vitro reconstitution assay, an excess of the P13-kinase subunit prevents this phosphorylation. Together, our results suggest that following insulin stimulation, P13-kinase associates with IRS 1, allowing for its serine phosphorylation. This phosphorylation event could play a role in the modulation of insulin signalling.
subunit to tyrosine-phosphorylated IRS 1 [11, 12] , and the p I 10 subunit catalyses the phosphorylation of phosphatidylinositol at the D3 position of the inositol ring. However, recent data have shown that the pl0 subunit also possesses a protein kinase activity [13] . It phosphorylates the p85 P13-kinase subunit on serine residues and this phosphorylation down-regulates the lipid kinase activity [13, 14] . So far, only p85 has been recognized as a substrate for the p1 10 serine kinase activity [13] . In this paper, we have investigated in the insulin-responsive 3T3-L1 adipocytes whether insulin stimulation causes a serine/threonine kinase to become associated with IRS 1 and to phosphorylate IRS 1. We have examined whether PI3-kinase could have such a role.
EXPERIMENTAL PROCEDURES Materials
Insulin was a gift from Lilly France (Paris). 5,5'-Dithiobis-(2-nitrobenzoic acid) (DTNB) and wortmannin were from Sigma. All other biochemicals were from Sigma or Serva (Heidelberg, Germany). Antibodies to IRS 1 and to the p85 subunit of the P13-kinase were from UBI (Lake Placid, NY, U.S.A.). PGEX 2T vector was from Pharmacia. Radiochemicals were from ICN or DuPont-New England Nuclear.
Cell culture 3T3-L1 cells were grown in 35-100 mm dishes in Dulbecco's modified Eagle's medium (DMEM) and 10% (v/v) fetal calf serum, and were induced to differentiate in adipocytes as described [6] . 3T3-L1 adipocytes were used [8] [9] [10] [11] [12] [13] [14] [15] (10 , uCi) . After 30 min at 25°C, the reaction was stopped by addition of Laemmli buffer. Samples were boiled and proteins were separated by SDS/PAGE using 7.5 % (w/v) polyacrylamide gels. These were dried and autoradiographed. When the effects of P13-kinase inhibitors were studied, experiments were performed as described above except that wortmannin (10 or 100 nM) or DTNB (300 ,uM) was added to the phosphorylation mixture.
Preparation of the glutathione S-transferase (GST)-p85(263-724) bacterial fusion proteins
A bacterial fusion protein containing the 263-724 fragment of bovine p85a was obtained as follows: a ScaI-StuI fragment (encompassing nt 785-2175, amino acids 263-724) from bovine p85a in Bluescript vector (a gift of M. D. Waterfield, Ludwig Institute, London) was subcloned into PGEX-2T vector (Pharmacia) at the SmaI site. Transformed bacteria (JM 109) were grown and induced with 1 mM isopropyl-l-thio-fl-Dgalactopyranoside for 3 h at 37 'C. Bacteria were lysed by two cycles of freezing and thawing in 30 ml of 50 mM Na2HPO4, pH 8.0, 0.3 M NaCl, I mM PMSF followed by 2 min of sonication. DNAase was added for 15 min at 4 'C. Soluble fractions were applied on a Glutathione Sepharose column (Pharmacia) and the fusion protein was eluted.
In vitro phosphorylation of IRS 1 and binding of P13-kinase
Human insulin receptors were purified using wheat germ agglutinin from NHIR cells and used to phosphorylate IRS I as described [6] . Briefly, IRS 1 was immunoprecipitated from 3T3-LI adipocytes. The beads were washed twice with stopping buffer containing 10% Nonidet-P40, twice with stopping buffer containing 0.5 M NaCl and twice with HNTV. Immune pellets were incubated with insulin receptors preincubated without or with insulin (100 nM); IRS 1 was phosphorylated for 15 min at room temperature by adding 10 #l of a reaction mixture containing 40 mM Hepes, pH 7.4, 24 mM MnCl2, 48 mM MgC12 and 120 ,uM ATP. The immune pellets were washed twice with stopping buffer containing 0.5 M NaCl and twice with stopping buffer containing 1 Nonidet-P40. Then P13-kinase binding to IRS 1 was performed as described [6] After 30 min at room temperature, the reaction was stopped by addition of Laemmli buffer and the proteins were analysed by SDS/PAGE and autoradiography.
Metabolic labelling of 3T3-L1 adipocytes 3T3-L1 adipocytes (cells from two 100 mm dishes/condition) were washed twice with PBS and incubated for 16 h at 37°C in methionine-and cysteine-free DMEM/10% fetal calf serum supplemented with Tran35S-label (ICN; 100 ,tCi/ml). Cells were washed twice with PBS and incubated for 4 h in 1O ml of methionine-and cysteine-free DMEM/0.5 % BSA supplemented with Trans 35S-label (100 ,uCi/ml). Then, cells were stimulated or not with 100 nM insulin for 7 min, washed with stopping buffer and solubilized in stopping buffer containing 10% Nonidet-P40.
Proteins were immunoprecipated with antibodies to IRS 1 as described above. After washes, immune pellets were resuspended in Laemmli buffer and subjected to linear gradient (7.5-15 % polyacrylamide) SDS/PAGE.
Phosphoamino acid analysis
Proteins were subjected to SDS/PAGE and transferred to poly(vinylidene difluoride) (PVDF) membranes. Sheets were autoradiographed and membrane segments containing IRS I or the 85 kDa subunit of the P13-kinase were cut, hydrolysed and analysed according to Kamps and Sefton [15] .
Immunoblotting experiments
Proteins were separated on SDS/PAGE, transferred to PVDF membranes, and the membranes were blocked with PBS/5% BSA for 4 h at room temperature. Membranes were incubated overnight at 4°C with antibodies to IRS 1 (1 ,ug/ml saturation buffer) or to the p85 subunit of the P13-kinase (1:1000 in saturation buffer). Sheets were then washed three times with PBS/I% Nonidet-P40 and incubated for 1 h at room temperature with 1251-protein A (5 x 105 c.p.m./ml of saturation buffer). After three washes, the membranes were autoradiographed.
RESULTS AND DISCUSSION
To determine whether a kinase able to phosphorylate IRS 1 was associated with immunopurified IRS 1, 3T3-L1 adipocytes were treated for various lengths of time with insulin and proteins were immunoprecipitated with antibodies to IRS 1. The kinase assay was performed on the immune pellet as described in the Experimental procedures section. As shown in Figure l 3T3-L1 adipocytes were stimulated for 2 min with 100 nM insulin and proteins were immunoprecipitated with antibodies to IRS 1. The in vitro kinase assay was performed in the absence or presence ot 300,uM DTNB (a) or wortmannin (10 or 100 nM) (b). Phosphorylated proteins were separated on SDS/PAGE and revealed by autoradiography.
devoid of kinase activity [3] , this observation suggests that the increase in IRS 1 phosphorylation is attributable to a kinase activity co-immunoprecipitating with IRS 1. Although part of IRS 1 could be associated with the insulin receptor [16] , it can be ruled out that IRS 1 phosphorylation resulted from the insulinreceptor tyrosine kinase activity because phosphoamino acid analysis indicated that this phosphorylation occurred only on serine residues.
To identify the kinase responsible for IRS 1 (Figure 2 ). When cells were stimulated with insulin, the mobility of IRS 1 slightly decreased because of its tyrosine phosphorylation [12] . Further, three proteins with a molecular mass of 85, 110 and 25 kDa respectively became associated with IRS 1 (Figure 2) . The 85 and 100 kDa proteins probably correspond to the two subunits of the P13-kinase [7] [8] [9] [10] , and the 25 kDa protein to GRB2 [17] . Among the SH2-domain-containing proteins previously described to bind to tyrosine-phosphorylated IRS 1, P13-kinase is the only kinase identified so far [1, 2] . Moreover, this kinase is a dual-specificity enzyme, as its p1 10 catalytic subunit possesses both a lipid kinase activity and a serine protein kinase activity [13] . The following experiments were undertaken to identify P13-kinase as the enzyme involved in IRS 1 phosphorylation in the anti-(IRS 1) immunoprecipitates. The serine protein kinase activity of p1 10, which has a thiol requirement for activity [13] , is sensitive to the sulphydryl-modifying reagent DTNB. As shown in Figure 3 , addition of 300 ,uM DTNB in the kinase assay inhibited in a parallel fashion the phosphorylation of p85 and IRS 1. Next, we studied the effect of wortmannin, which is considered to be a selective inhibitor of P13-kinase, when it was used at concentrations between 10 and 100 nM [18] [19] [20] . Addition Figure 4 An excess of GST-p85 blocks the serine kinase activity towards Figure 4 , immunopurified IRS I from unstimulated cells was phosphorylated with unlabelled ATP by insulin receptors activated or not a source of P13-kinase, was incubated with an excess of GST or and was added to the immune pellet. Then, IRS 1 phosphorylation was performed as described in the Experimental procedures section. As shown in Figure 4, (Figure 1 ). When the same experiment was performed with a 3T3-LI lysate containing an excess of . Thus, an excess of GSTp85(263-724) is able to prevent the association of a functional p85-pI 10 PI3-kinase complex to IRS 1, and concomitantly the phosphorylation of IRS 1 is markedly reduced. The basal IRS 1 phosphorylation was not prevented after addition of GSTp85(263-724) (lane C), suggesting that it was not attributable to P13-kinase.
Taken together, our results strongly suggest that the serine phosphorylation of IRS I is mediated by P13-kinase. Although, so far, p85 has been considered as the only substrate for the pI IO serine kinase [13] , our results indicate that p1 10 is able to catalyse phosphorylation reactions towards another protein. The pl10 serine kinase activity did not phosphorylate proteins such as myelin basic protein (results not shown ), enolase or histone [13] .
Further, GRB2, which is also associated to IRS 1 ([17] and Figure 2 ), was not phosphorylated in our in vitro kinase assay (results not shown). The binding of p85 to p 10 appears to be required for the serine phosphorylation of p85 [13] , suggesting that the substrate must be brought into close proximity to the active site of the enzyme. Thus, insulin-induced tyrosine phosphorylation of IRS 1, which allows for the binding of P13-kinase to IRS 1, might also favour the subsequent serine phosphorylation of IRS I by the pi 10 catalytic subunit of P13-kinase.
The data presented in this paper were obtained in vitro, and thus a key question is whether such a process is also occurring in vivo. However, it is tempting to suggest that it might play a role in regulation of insulin action. Serine/threonine phosphorylation events are known to be involved in down-regulation of insulin signalling. For instance, serine/threonine phosphorylation of the insulin receptor by protein kinase C or by cAMP-dependent protein kinase inhibits insulin-stimulated receptor tyrosine phosphorylation [23] [24] [25] [26] [27] [28] . In cells treated with okadaic acid, phosphorylation of IRS 1 on serine/threonine residues reduces its tyrosine phosphorylation by the insulin receptor, leading to a reduction in the activation of P13-kinase and in the stimulation of glucose transport [6] . Further, in adipocytes and fibroblasts, an increase in intracellular cAMP level attenuates the insulininduced activation of mitogen-activated protein kinase [29, 30] . Finally, in 3T3-LI adipocytes which are desensitized to insulin action because of long-term treatment with the hormone, the amount of IRS I is reduced and its degree of serine phosphorylation is increased [31, 32] . Interestingly, P13-kinase activation seems to be required for this process, as a P13-kinase inhibitor blocks the insulin-induced degradation of IRS 1 Note added in proof (received 20 September 1994) During the submission of this report, another study appeared on the phosphorylation of IRS 1 by the P13-kinase serine kinase [34] .
